NOW Vitamin D3 1,000 IU & K2 45mcg Caps 120’s (NEW) in Kenya

Product Summary

A synergistic formula combining 1,000 IU of Vitamin D3 (cholecalciferol) and 45mcg of Vitamin K2 (as MK-7) per softgel. This NEW duo optimizes calcium utilization for bone density, cardiovascular health, and immune resilience. The 120-softgel bottle offers a 4-month supply, designed to address Kenya’s dual burden of Vitamin D deficiency and cardiovascular risks.

Key Benefits

• Bone Density Optimization: D3 enhances calcium absorption; K2 (MK-7) directs calcium to bones (not arteries), reducing fracture risk.
• Cardiovascular Protection: K2 prevents arterial calcification, supporting healthy blood vessels.
• Immune & Mood Support: D3 regulates immune cells and neurotransmitters; K2 reduces inflammation.
• Synergistic Absorption: K2 activates D3-dependent proteins, maximizing efficacy.
• Deficiency Correction: Targets Kenya’s 84% D3 deficiency while countering K2 scarcity in local diets.

Composition

• Active Ingredients per Softgel:

  Component	Amount	Function
  Vitamin D3 (Cholecalciferol)	1,000 IU (25 mcg)	Calcium absorption, immune regulation
  Vitamin K2 (as Menaquinone-7)	45mcg	Activates osteocalcin, inhibits vascular calcification

• Other Ingredients:
  • Extra virgin olive oil, gelatin (softgel), glycerin, purified water.
• Free From:
  • Gluten, GMOs, dairy, soy, nuts, artificial additives.
• Bioavailability:
  • Fat-soluble; best absorbed with dietary fats. MK-7 has 72-hour half-life for sustained action.

How to Use

• Dosage: Take 1 softgel daily with a fat-containing meal.
• Critical Timing:
  • With breakfast or lunch (e.g., with avocado, eggs, nuts, or whole milk).
  • Avoid evening doses (D3 may disrupt sleep in sensitive individuals).
• Duration:
  • Maintenance: Safe for long-term use.
  • Deficiency Correction: 1 softgel daily for 6–12 months (confirm with blood test).
• Note:
  • Do not exceed 1 softgel daily without medical supervision.
  • Swallow whole; do not puncture softgel.

Potential Side Effects

• Generally Safe: Well-tolerated at 1,000 IU D3 + 45mcg K2 daily.
• Possible Reactions:
  • Mild nausea, constipation, or fatigue (rare).
  • Allergic reactions (rash, itching) in sensitive individuals.
• Serious Risks:
  • Hypercalcemia (elevated blood calcium) only with prolonged high-dose D3 use (>4,000 IU/day).
  • K2 Interactions: May reduce efficacy of blood thinners (e.g., warfarin).
• Precautions:
  • Avoid if:
    • Hypercalcemia, sarcoidosis, or kidney disease.
    • Taking blood thinners (e.g., warfarin, aspirin) or anticonvulsants.
  • Consult a doctor if:
    • Pregnant/nursing (safe at standard doses; high doses require monitoring).
    • On cholesterol-lowering meds or chemotherapy.

Frequently Asked Questions (FAQs)

1. How long does one bottle last?

At 1 softgel daily, a 120-count bottle lasts 120 days (4 months).

2. Why combine D3 and K2?

• D3 boosts calcium absorption.
• K2 acts as a “traffic cop,” directing calcium to bones (not arteries).
  Without K2, excess calcium may deposit in blood vessels.

3. Is this safe for Kenyans with high sun exposure?

Yes. Despite equatorial sun, 84% of Kenyan adults are D3-deficient due to:

• Melanin blocking UVB.
• Cultural clothing (e.g., buibui, hijabs).
• Urban pollution (Nairobi’s PM2.5 reduces UV penetration).

4. Can children use this?

Yes for children 4+. Use 1 softgel daily. Under 4: Consult pediatrician (dose: 400–600 IU D3 + 20–30mcg K2).

5. How does this benefit Kenyan users?

• Bone Health: Counters osteoporosis in 60% of Kenyan women >50.
• Heart Protection: Reduces arterial calcification (rising hypertension rates in Kenya).
• Cost Savings: 4-month supply costs ~KES 4,000–5,000 (vs. KES 8,000+ for separate supplements).

6. Does it interact with malaria meds?

No. Safe with artemisinin-based therapies.

7. Will it cause sun sensitivity?

No. Neither D3 nor K2 increases photosensitivity.

8. Can I open the softgel?

Not recommended. Oil may oxidize; use liquid forms if needed.

Who Can Benefit?

• Adults with Vitamin D deficiency (fatigue, bone pain, frequent infections).
• High-Risk Groups:
  • Elderly (>60) with osteoporosis risk.
  • Dark-skinned individuals (melanin blocks UVB).
  • Urban dwellers with limited sun exposure.
• Health Priorities:
  • Cardiovascular Support: Those with hypertension or family history of heart disease.
  • Bone Preservation: Postmenopausal women or individuals with low calcium intake.
• Not for: Those on blood thinners (K2 counteracts anticoagulants).